Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

530.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 913.00
  • 52 Week Low: 424.00
  • Currency: UK Pounds
  • Shares Issued: 121.46m
  • Volume: 188,532
  • Market Cap: £643.74m
  • RiskGrade: 125
  • Beta: 0.03

Latest ShareCast News

Director dealings: Oxford Biomedica chair ups stake

By Benjamin Chiou

Date: Thursday 24 Sep 2026

(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.

OXB Regulatory News

Total Voting Rights 02-Nov-2026 07:00 RNS
Appointment of Independent Non-Executive Director 16-Oct-2026 07:00 RNS
Admission to Trading 09-Oct-2026 09:11 RNS
PDMR Dealing 06-Oct-2026 14:43 RNS
Admission to Trading 06-Oct-2026 10:36 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 530.00p
Change Today -5.00p
% Change -0.93 %
52 Week High 913.00
52 Week Low 424.00
Volume 188,532
Shares Issued 121.46m
Market Cap £643.74m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.27% below the market average65.27% below the market average65.27% below the market average65.27% below the market average65.27% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
85.72% above the market average85.72% above the market average85.72% above the market average85.72% above the market average85.72% above the market average
62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average
Income Not Available
Growth
48.27% above the market average48.27% above the market average48.27% above the market average48.27% above the market average48.27% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 13-Nov-2026

Time Volume / Share Price
16:35 56,177 @ 530.00p
16:35 3,730 @ 530.00p
16:35 409 @ 530.00p
16:35 1,239 @ 530.00p
16:35 181 @ 530.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page